Koers Radiko Holdings Corp. Canadian Securities Exchange
Aandelen
JUJU
CA75034R1029
Farmaceutische producten
Omzet 2018 | 107K 145K 97,98K | Omzet 2019 | 5,18 mln. 7,05 mln. 4,76 mln. | Marktkapitalisatie | 6,17 mln. 8,39 mln. 5,67 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -4 mln. -5,44 mln. -3,68 mln. | Nettowinst (verlies) 2019 | -10 mln. -13,6 mln. -9,19 mln. | EV/omzet 2018 | 101 x |
Nettoschuld 2018 | 259K 352K 238K | Nettoschuld 2019 | 1,98 mln. 2,69 mln. 1,82 mln. | EV/omzet 2019 | 1,57 x |
K/w-verhouding 2018 |
-1,5
x | K/w-verhouding 2019 |
-0,53
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 96,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16-04-18 |
David Rosenberg
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-19 |
Scott Reeves
BRD | Director/Board Member | 55 | 01-02-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Gormley
CEO | Chief Executive Officer | 55 | 16-04-18 |
Scott Reeves
BRD | Director/Board Member | 55 | 01-02-17 |
Robert Yosaitis
BRD | Director/Board Member | - | 12-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,37% | 588 mld. | |
-2,79% | 364 mld. | |
+20,37% | 326 mld. | |
+5,52% | 285 mld. | |
+14,83% | 239 mld. | |
+9,93% | 210 mld. | |
-6,95% | 200 mld. | |
+11,05% | 167 mld. | |
-0,09% | 161 mld. |